Yogev Debbi is the co-founder and CEO of Mana.bio. Previously, after working for years at the tech industry at Intel Corporation (Nasdaq:INTC), he co-founded and was the COO of Genome Compiler, a software gene editing company acquired by Twist Bioscience (Nasdaq:TWST), where he then led Twist's Israel R&D center through its IPO. Yogev brings deep expertise in launching and scaling successful bioengineering startups. As a repeat entrepreneur, Yogev is excited about the integration of software and biology and he is focused on leveraging the integration of the two fields to create disruptive technologies to positively impact human health.